These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 25438255

  • 1. Subchronic lithium treatment increases the anxiolytic-like effect of mirtazapine on the expression of contextual conditioned fear.
    An Y, Inoue T, Kitaichi Y, Nakagawa S, Wang C, Chen C, Song N, Kusumi I.
    Eur J Pharmacol; 2015 Jan 15; 747():13-7. PubMed ID: 25438255
    [Abstract] [Full Text] [Related]

  • 2. Combined treatment with subchronic lithium and acute intracerebral mirtazapine microinjection into the median raphe nucleus exerted an anxiolytic-like effect synergistically.
    An Y, Inoue T, Kitaichi Y, Chen C, Nakagawa S, Wang C, Kusumi I.
    Eur J Pharmacol; 2016 Jul 15; 783():112-6. PubMed ID: 27154172
    [Abstract] [Full Text] [Related]

  • 3. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
    Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T.
    Eur J Pharmacol; 2006 Feb 27; 532(3):236-45. PubMed ID: 16487506
    [Abstract] [Full Text] [Related]

  • 4. Mirtazapine exerts an anxiolytic-like effect through activation of the median raphe nucleus-dorsal hippocampal 5-HT pathway in contextual fear conditioning in rats.
    An Y, Chen C, Inoue T, Nakagawa S, Kitaichi Y, Wang C, Izumi T, Kusumi I.
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct 03; 70():17-23. PubMed ID: 27137833
    [Abstract] [Full Text] [Related]

  • 5. Anxiolytic-like effect of mirtazapine mediates its effect in the median raphe nucleus.
    An Y, Inoue T, Kitaichi Y, Izumi T, Nakagawa S, Song N, Chen C, Li X, Koyama T, Kusumi I.
    Eur J Pharmacol; 2013 Nov 15; 720(1-3):192-7. PubMed ID: 24436979
    [Abstract] [Full Text] [Related]

  • 6. Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: Functional significance of 5-hydroxytryptamine 1A receptor and alpha1-adrenergic receptor.
    Kakui N, Yokoyama F, Yamauchi M, Kitamura K, Imanishi T, Inoue T, Koyama T.
    Pharmacol Biochem Behav; 2009 May 15; 92(3):393-8. PubMed ID: 19167420
    [Abstract] [Full Text] [Related]

  • 7. Yokukansan, a traditional Japanese herbal medicine, enhances the anxiolytic effect of fluvoxamine and reduces cortical 5-HT2A receptor expression in mice.
    Ohno R, Miyagishi H, Tsuji M, Saito A, Miyagawa K, Kurokawa K, Takeda H.
    J Ethnopharmacol; 2018 Apr 24; 216():89-96. PubMed ID: 29382554
    [Abstract] [Full Text] [Related]

  • 8. SSR504734, a glycine transporter-1 inhibitor, attenuates acquisition and expression of contextual conditioned fear in rats.
    Nishikawa H, Inoue T, Izumi T, Nakagawa S, Koyama T.
    Behav Pharmacol; 2010 Sep 24; 21(5-6):576-9. PubMed ID: 20613495
    [Abstract] [Full Text] [Related]

  • 9. [Behavioral and neurochemical study on the mechanism of the anxiolytic effect of a selective serotonin reuptake inhibitor, a selective serotonin1A agonist and lithium carbonate].
    Muraki I.
    Hokkaido Igaku Zasshi; 2001 Mar 24; 76(2):57-70. PubMed ID: 11344903
    [Abstract] [Full Text] [Related]

  • 10. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
    Yamaguchi T, Tsujimatsu A, Kumamoto H, Izumi T, Ohmura Y, Yoshida T, Yoshioka M.
    J Ethnopharmacol; 2012 Sep 28; 143(2):533-9. PubMed ID: 22819689
    [Abstract] [Full Text] [Related]

  • 11. Effect of a dopamine D1/5 receptor antagonist on haloperidol-induced inhibition of the acquisition of conditioned fear.
    Inoue T, Izumi T, Li XB, Kitaichi Y, Nakagawa S, Koyama T.
    Eur J Pharmacol; 2005 Sep 20; 519(3):253-8. PubMed ID: 16135362
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the anxiolytic-like effects of fluvoxamine, milnacipran and risperidone in mice using the conditioned fear stress paradigm.
    Miyamoto J, Tsuji M, Takeda H, Ohzeki M, Nawa H, Matsumiya T.
    Eur J Pharmacol; 2004 Nov 03; 504(1-2):97-103. PubMed ID: 15507225
    [Abstract] [Full Text] [Related]

  • 13. Anti-aversive effects of the atypical antipsychotic, aripiprazole, in animal models of anxiety.
    Biojone C, Casarotto PC, Resstel LB, Zangrossi H, Guimarães FS, Moreira FA.
    J Psychopharmacol; 2011 Jun 03; 25(6):801-7. PubMed ID: 20699351
    [Abstract] [Full Text] [Related]

  • 14. Low level lindane exposure alters extinction of conditioned fear in rats.
    Cloutier S, Forquer MR, Sorg BA.
    Toxicology; 2006 Jan 16; 217(2-3):147-54. PubMed ID: 16213647
    [Abstract] [Full Text] [Related]

  • 15. Prior chronic nicotine impairs cued fear extinction but enhances contextual fear conditioning in rats.
    Tian S, Gao J, Han L, Fu J, Li C, Li Z.
    Neuroscience; 2008 Jun 02; 153(4):935-43. PubMed ID: 18440720
    [Abstract] [Full Text] [Related]

  • 16. Effects of cytochrome P450 (CYP) 3A4 inhibitors on the anxiolytic action of tandospirone in rat contextual conditioned fear.
    Nishikawa H, Inoue T, Masui T, Izumi T, Koyama T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May 09; 31(4):926-31. PubMed ID: 17376576
    [Abstract] [Full Text] [Related]

  • 17. Modulatory effect of diphenyl diselenide in Carioca High- and Low-conditioned Freezing rats.
    Hassan W, Silva CE, Rocha JB, Landeira-Fernandez J.
    Eur J Pharmacol; 2015 Aug 15; 761():341-4. PubMed ID: 26086858
    [Abstract] [Full Text] [Related]

  • 18. The pharmacokinetics and pharmacodynamics of tandospirone in rats exposed to conditioned fear stress.
    Nishitsuji K, To H, Shimizu T, Yanase Y, Yamada T, Hara C, Mine K, Higuchi S.
    Eur Neuropsychopharmacol; 2006 Jul 15; 16(5):376-82. PubMed ID: 16406508
    [Abstract] [Full Text] [Related]

  • 19. Effects of acute and subchronic treatments with fluoxetine and desipramine on the memory of fear in moderate and high-intensity contextual conditioning.
    Santos JM, Martinez RC, Brandão ML.
    Eur J Pharmacol; 2006 Aug 07; 542(1-3):121-8. PubMed ID: 16831418
    [Abstract] [Full Text] [Related]

  • 20. Effect of MS-153 on the acquisition and expression of conditioned fear in rats.
    Li X, Inouei T, Abekawai T, YiRui F, Koyama T.
    Eur J Pharmacol; 2004 Nov 28; 505(1-3):145-9. PubMed ID: 15556147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.